APINI THERAPEUTICS LIMITED
Research and experimental development on biotechnology
APINI THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Burnham House Splash Lane Wyton Huntingdon PE28 2AF England
Full company profile for APINI THERAPEUTICS LIMITED (13767202), an active company based in Huntingdon, England. Incorporated 26 Nov 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Cash in Bank
£1.08M
Net Assets
£1.06M
Total Liabilities
£265.51k
Turnover
N/A
Employees
1
Debt Ratio
20%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Isaac, John Timothy Roger, Dr | Director | British | United Kingdom | 7 Nov 2025 | Active |
| Nathaniel Dahan | Director | French | England | 13 Aug 2024 | Active |
| Sam Butterworth | Director | British | England | 26 Nov 2021 | Active |
See all 7 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Slingshot Therapeutics Holdings Limited
United Kingdom
- Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent
Sam Butterworth
Ceased 13 Aug 2024
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 5 Dec 2025 | Confirmation Statement | Confirmation statement made on 2025-11-25 with updates | |
| 14 Nov 2025 | Officers | Appointment of Dr John Timothy Roger Isaac as director on 2025-11-07 | |
| 14 Nov 2025 | Officers | Termination of Richard Wooster as director on 2025-11-07 | |
| 29 Jul 2025 | Change Of Name | Replacement filing of SH01 - 08/07/25 Statement of Capital gbp 42.35144 | |
| 24 Jul 2025 | Persons With Significant Control | Change to Slingshot Therapeutics Holdings Limited as a person with significant control on 2025-07-08 |
Confirmation statement made on 2025-11-25 with updates
Appointment of Dr John Timothy Roger Isaac as director on 2025-11-07
Termination of Richard Wooster as director on 2025-11-07
Replacement filing of SH01 - 08/07/25 Statement of Capital gbp 42.35144
Change to Slingshot Therapeutics Holdings Limited as a person with significant control on 2025-07-08
Recent Activity
Latest Activity
Confirmation statement made on 2025-11-25 with updates
4 months ago on 5 Dec 2025
Appointment of Dr John Timothy Roger Isaac as director on 2025-11-07
5 months ago on 14 Nov 2025
Termination of Richard Wooster as director on 2025-11-07
5 months ago on 14 Nov 2025
Replacement filing of SH01 - 08/07/25 Statement of Capital gbp 42.35144
9 months ago on 29 Jul 2025
Change to Slingshot Therapeutics Holdings Limited as a person with significant control on 2025-07-08
9 months ago on 24 Jul 2025